Synaptic Injury and Functional Connectivity in Alzheimer's Disease
Cerebrospinal Fluid Markers of Synaptic Injury and Functional Connectivity in Alzheimer's Disease
Sponsor: Ohio State University
This observational or N/A phase trial investigates Alzheimer Disease, Late Onset and is currently completed. Ohio State University leads this study, which shows 15 recorded versions since 2018 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
15 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Oct 2021 — Dec 2021 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Sep 2021 — Oct 2021 [monthly]
Active Not Recruiting
▶ Show 10 earlier versions
-
Apr 2021 — Sep 2021 [monthly]
Active Not Recruiting
-
Jan 2021 — Apr 2021 [monthly]
Active Not Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Active Not Recruiting
-
Apr 2020 — Nov 2020 [monthly]
Active Not Recruiting
-
Feb 2019 — Apr 2020 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Aug 2018 — Feb 2019 [monthly]
Recruiting
-
Jun 2018 — Aug 2018 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Oct 2017 — Apr 2018 [monthly]
Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Ohio State University
For direct contact, visit the study record on ClinicalTrials.gov .